Search results for "tunneling nanotubes"

showing 2 items of 2 documents

Unraveling In vivo brain transport of protein‐coated fluorescent nanodiamonds

2019

The blood–brain barrier is the biggest hurdle to overcome for the treatment of neurological disorders. Here, protein‐coated nanodiamonds are delivered to the brain and taken up by neurovascular unit cells after intravenous injection. Thus, for the first time, nanodiamonds with their unique properties and a flexible protein coating for the attachment of therapeutics emerge as a potential platform for nanotheranostics of neurological disorders.Nanotheranostics, combining diagnostics and therapy, has the potential to revolutionize treatment of neurological disorders. But one of the major obstacles for treating central nervous system diseases is the blood–brain barrier (BBB) preventing systemic…

Cell SurvivalCentral nervous systemnanotheranosticsTunneling (Physics)Serum Albumin Human02 engineering and technology010402 general chemistryBlood–brain barrier01 natural sciencesFluorescencePolyethylene GlycolsNanodiamondsBiomaterialstunneling nanotubesMiceIn vivoCell MovementmedicineAnimalsBlut-Hirn-SchrankeGeneral Materials Scienceddc:610Blood-brain barrierNeuronsNanotubesChemistryBrainEndothelial CellsBiological TransportGeneral ChemistryHospitals Drug distribution systems021001 nanoscience & nanotechnologyHuman serum albuminPhotobleachingIn vitroEndocytosis0104 chemical sciencesmedicine.anatomical_structureTranscytosisBlood-Brain BarrierNanoröhreAstrocytesDrug deliverydrug deliveryBiophysics0210 nano-technologyDDC 610 / Medicine & healthBiotechnologymedicine.drug
researchProduct

Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis

2023

Pyrrolomycins (PMs) are a family of naturally occurring antibiotic agents, isolated from the fermentation broth of Actinosporangium and Streptomyces species. Pursuing our studies on pyrrolomycins, we performed the total synthesis of the F-series pyrrolomycins (1–4) by microwave-assisted synthesis (MAOS), thus obtaining the title compounds in excellent yields (63–69%). Considering that there is no evidence so far of the anticancer effect of this class of compounds, we investigated PMs for their antiproliferative activity against HCT116 and MCF-7 cancer cell lines. PMs showed anticancer activity at submicromolar level with a minimal effect on normal epithelial cell line (hTERT RPE-1), and the…

PharmacologyOrganic ChemistryDrug DiscoveryPyrrolomycin Anticancer activity Microwave-assisted organic synthesis (MAOS) Vacuoles Tunneling nanotubes (TNTs) FilopodiaGeneral MedicineSettore BIO/06 - Anatomia Comparata E CitologiaSettore CHIM/08 - Chimica FarmaceuticaEuropean Journal of Medicinal Chemistry
researchProduct